InvestorsHub Logo
Followers 0
Posts 294
Boards Moderated 0
Alias Born 09/15/2016

Re: None

Wednesday, 08/26/2020 12:05:12 PM

Wednesday, August 26, 2020 12:05:12 PM

Post# of 3647
Compounding the Venturis failures: The Tell

What's really interesting to me is that Venturis Therapeutics shareholders focus on the company, asking questions (which do not get answered) like:

1) Why has Venturis failed to run a single clinical trial since 2007?

2) Why hasn't Venturis held the shareholders meeting in 2020 as required by the bylaws?

3) Why does Venturis Therapeutics often seek to (clumsily) cover up bad news rather than just forthrightly acknowledge it?

4) Why doesn't Venturis Therapeutics announce all the money it has raised and indicate who has invested, as is the norm in this industry and in fact in the history in this company? (we know why - there isn't any
)


Yet the company's supporters (who I believe are actually just the leadership team in disguise) seem to only want to talk about one subject in response: Dan Montano, the former CEO who was ousted in a hostile takeover in 2013. It's all Dan Montano, all the time. That alone is the tell. Not only is it a poor attempt to change the subject, but it's an acknowledgement that everything the critics are saying is true. Well, at least we critics are flattered.

Yes, it's probably not pleasant for the leadership to talk about its consistent legacy of failures, lies, distortions, and broken promises. Yes, it's probably not pleasant for the leadership to admit they've failed miserably and bankruptcy is now at hand. But still, it's so OBVIOUS that their pathetic efforts to re-litigate events of 7 years ago, and this obsessive fixation on someone long gone, is a ridiculous and unsuccessful attempt to cover up a dismal record of failure, lies and deceit. Awesome reults for sure!

And of course, look at the leadership itself:

A) Calvin Wallen III is an accused crook by the U.S. government, who the government alleges stole $14 million from his previous company. His trial awaits him. And we need to note that Mr. Wallen has taken a scorched earth approach to delay, delay, delay, delay his trial. It's worked - it's three years now (although in his defense, Mr. Wallen had a great assist from coronavirus). Certainly this is the sign of someone who thinks they are innocent, right? And it's clear he's innocent too, because even though the government hired forensic accountants who discovered his alleged fraud and identified the dates, times, amounts, and recipient bank accounts where the money was siphoned off to for no valid business purpose, this is nothing less than the Deep State rearing its ugly head to smear and attack Trump supporters. Or something like that...

B) And then there's Grant Gordon, who also has repeated allegations of impropriety around him (although he is not facing a trial to the best of my knowledge). But I don't harp on Grant Gordon to the degree he deserves because he is reportedly not doing well.

C) And of course we can't let the dysfunctional Board of Directors off the hook. Can someone else name a company where the CEO is accused of fraud by the U.S. government yet the Board has not taken the appropriate and prudent step of removing him until the matter is legally resolved? Let's face it, we shareholders do not have a Board of Directors that is looking out after our interests. In my opinion it's a corrupt group of sycophants who are simply doing Mr. Wallen's bidding. It's disgusting. The only board member besides Grant Gordon who has reared his head is Jon Ross, who spoke at one shareholders meeting. At that meeting, he acknowledged in response to a shareholder question that Venturis (called CVBT at the time) was paying only one employee in cash. Way to go, Jon! After that, Jon was sent to the Cone of Silence, from which he has not emerged since.

It's over soon, folks. For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.